[1]
|
官家乐, 高原, 高鸿慈. 手性药物[J]. 中国医院医学杂志, 2001, 21(7): 443-445.
|
[2]
|
马纪伟, 闰东良. 手性和手性药物[J]. 井冈山医专学报, 2005, 12(3): 24-26.
|
[3]
|
顿彬, 刘会臣. 手性药物对映体在药效学与药代动力学的相互作用[J]. 中国临床药理学杂志, 2005, 22(1): 66-69.
|
[4]
|
杜建红, 夏叔泉. 手性药物发展中的外消旋体和对映体[J]. 国外医药-合成药、生化药、制剂分册(world pharmacy), 1994, 15(4): 206-208.
|
[5]
|
Turk, E., Zabel, B., Mundlos, S., et al. (1991) Glucose/Galactose Malabsorption Caused by a Defect in the Na+/Glucose Cotransporter. Nature, 350, 354-356. https://doi.org/10.1038/350354a0
|
[6]
|
孟飞. 手性药物开发战略及研究进展[J]. 医药化工, 2004(8): 12-18.
|
[7]
|
王艳波, 张瑛, 聂文辉. 开发生产手性药物的重要意义[J]. 首都医药, 2005, 12(22): 25.
|
[8]
|
华维一, 许国友. 手性药物手性、药理作用与新药开发[J]. 现代应用医学, 1993, 10(3): 4-7.
|
[9]
|
Yamate, J., Sato, K., Ide, M., et al. (2002) Participation of Different Macrophage Populations and Myofibroblastic Cells in Chronically Developed Renal Interstitial Fibrosis after Cisplatin-Induced Renal Injury in Rats. Veterinary Pathology, 39, 322-333. https://doi.org/10.1354/vp.39-3-322
|
[10]
|
白蕾, 霍淑慧, 陈晶. 用于手性识别α-氨基酸的方酰胺荧光探针分子[J]. 分析化学, 2019, 40(1): 41-46.
|
[11]
|
朱宇萍, 倪萍. 还原氧化石墨烯/硫堇复合物修饰的手性表面对色氨酸的选择性识别[J]. 吉林大学学报(理学版), 2018, 56(5): 1278-1284.
|
[12]
|
吴超飞. 手性溶剂化法识别的研究进展[J]. 开发与应用, 2018, 47(6): 546-548.
|
[13]
|
Kawano, S., Horikawa, M., Yasohara, Y., et al. (2003) Microbial Enztioselective Reduction of Acetylpyridine Derivatives. Bioscience, Biotechnology, and Biochemistry, 67, 809-815. https://doi.org/10.1271/bbb.67.809
|
[14]
|
郭莉娜, 陈灿, 黄明智, 等. 不对称催化反应合成手性药物的研究进展[J]. 精细化工中间体, 2006, 36(2): 1-5.
|
[15]
|
丁慈. 手性药物的开发与前景[J]. 中国医药情报, 1998(4): 83-85.
|
[16]
|
王普善, 王宇梅. 手性药物开发战略的再认识[J]. 精细与专用化学品, 2004, 12(10): 4-7.
|
[17]
|
Kanai, Y., Lee, W.S., You, G., et al. (1994) The Human Kidney Low Affinity Na+/Glucose Cotransporter SGLT2. Delineation of the Major Renal Reabsorptive Mechanism for D-Glucose. Journal of Clinical Investigation, 93, 397-404. https://doi.org/10.1172/JCI116972
|
[18]
|
张宇. 手性药物研究取得重要进展[J]. 中国医药技术与市场, 2005, 5(4): 37.
|
[19]
|
丁慈. 手性药物研究进展和国内市场[J]. 制药原料及中间体信息, 2005(12): 27-28.
|
[20]
|
钱鸣蓉, 陈亚坤, 曾苏. 手性药物的研究策略[J]. 中国现代应用医学, 2004, 21(6): 461-464.
|
[21]
|
Jin, D.Q., Yin, S.N. and Mu, Y.M. (2007) Advance in Research of PPAR. Chinese Journal of Drug Application and Monitoring, 4, 46-49.
|
[22]
|
Cai, L. and Liu, P. (2010) Dipeptidyl Peptidase IV Inhibitors: A New Class of Oral Agents for Treatment of Type 2 Diabetes Mellitus. Journal of International Pharmaceutical Research, 37, 361-365.
|
[23]
|
Tong, S.Q., Guan, Y.X., Yan, J.Z., et al. (2011) Enantiomeric Separation of (R,S)-Naproxen by Recycling High Speed Counter-Current Chromatography with Hydroxypropyl-β-cyclodextrin as Chiral Selector. Journal of Chromatography A, 1218, 5434-5440. https://doi.org/10.1016/j.chroma.2011.06.015
|
[24]
|
谢娜. 高速逆流色谱拆分酮康唑等三种手性药物的研究[D]: [硕士学位论文]. 湘潭: 湘潭大学, 2016.
|
[25]
|
Ennarz, W.J. (2006) Encyclopedia of Biological Chem-istry. Science Press, 208-212.
|
[26]
|
Hediger, M.A. and Rhoads, D.B. (1994) Molecular Physiology of Sodium-Glucose Cotransporters. Physiological Reviews, 74, 993-1026. https://doi.org/10.1152/physrev.1994.74.4.993
|
[27]
|
成化. “手性药物国家工程研究中心”项目通过评估[J]. 中国西部科技, 2005(11): 15.
|
[28]
|
List, J.F., Woo, V., Morales, E., et al. (2009) Sodium-Glucose Cotransport Inhibition with Dapagliflozin in Type 2 Diabetes. Diabetes Care, 32, 650-657. https://doi.org/10.2337/dc08-1863
|
[29]
|
Ehrenkranz, J.R.L., Lewis, N.G., Kahn, C.R., et al. (2005) Phlorizin: A Review. Diabetes/Metabolism Research and Reviews, 21, 31-38. https://doi.org/10.1002/dmrr.532
|
[30]
|
李全, 谢毓云. 手性药物的光学异构体与药效[J]. 中国手性药物化学杂志, 1996, 6(2): 151-154.
|
[31]
|
于平, 岑沛霖, 励建荣. 手性化合物制备的方法[J]. 生物工程进展, 2001, 21(6): 89-92.
|
[32]
|
Imamura, M., Murakami, T., Shiraki, R., et al. (2004) C-Glycoside Derivatives and Salts There of. PCT/JP2004/0033324. 2004-12-03.
|
[33]
|
Mascitti, V. and Ville, C.P. (2010) Stereoselective Synthesis of a Dioxa-Bicyclo[3.2.1]octane SGLT2 Inhibitor. Organic Letters, 12, 2940-2943. https://doi.org/10.1021/ol100940w
|